MedPath

The Effect of Okra on Endurance in Recreational Runners

Phase 2
Registration Number
CTRI/2024/06/069625
Lead Sponsor
Arjuna Natural Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Males and Females 25 to 40 years of age (1:1 ratio)

Body Mass Index between from 18.5 to 24.9 kg/m2

Being recreationally active – Habitual running for 30 min for at least 3 days in a week for the past 3 months.

IPAQ vigorous activity not less than 720 MET minutes per week.

Normotensive (seated, resting systolic blood pressure less than 140 mm Hg and diastolic blood

pressure less than 90 mm Hg. Normal seated, resting heart rate (less than 90 beats per minute).

Subjects who are willing to refrain from using protein, vitamin, mineral and herbal supplements for the study period.

Ability to follow all instructions in the study protocol and be willing to give written

informed consent.

Exclusion Criteria

COVID positive in the past 6 months.

Received any vaccinations in the past 6 months.

Current use of prescription or over-the-counter medications or unwillingness or inability to discontinue use of these medications at least 4 weeks before beginning the study.

Cardiovascular complications.

Use of protein, vitamin, mineral, and herbal supplements 1 week before the study.

Alcoholic (greater than 2 pegs(60ml)per day) and smoking (has not stopped within 3 months of the study)

Medical problems that would be a direct physical limitation.

Current treatment for depression, alcohol or substance abuse, or psychosis

Women of childbearing age intending for pregnancy or are pregnant, breastfeeding, or willing to practice contraception.

Any condition, including laboratory abnormalities, that in the opinion of investigator places the volunteer at an unacceptable risk or deems the volunteer not suitable for participation in the study.

Subjects who are unwilling to abstain from consuming okra and any other dietary supplements and to maintain their normal training and dietary habits.

Subjects who participated in a clinical trial for the past 3 months.

Unwilling to provide written informed consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath